Novartis reported CHF121.21B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alcon AG ALC:SW 27.8B 52M
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Bayer BAYN:GR € 116549M 2122M
Biogen BIIB:US $ 23806.7M 663.7M
Bristol Myers Squibb BMY:US $ 110893M 96M
Eli Lilly And LLY:US $ 48187M 378M
Fresenius FRE:GR € 71081M 1426M
Fresenius Medical Care FME:GR € 33831M 843.79M
Galapagos GLPG:NA € 5331.99M 98.63M
Genmab GEN:DC DK 23985M 1502M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
GRIFOLS GRF:SM € 16213.05M 75.45M
H. Lundbeck A/S LUN:DC 35.12B 1.08B
Hikma Pharmaceutical HIK:LN 4.18B 45M
Lonza Group LONN:SW 15.16B 732M
Merck MRK:GR € 43836M 691M
Novartis NOVN:VX SF 121209M 2806M
Novartis NVS:US $ 121209M 2806M
Orion ORNBV:FH € 1056.1M 14.7M
Recordati REC:IM € 2929.54M 53.63M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M